TG Therapeutics, Inc. (TGTX)
39.52
-1.27
(-3.11%)
USD |
NASDAQ |
May 15, 16:00
39.62
+0.10
(+0.25%)
Pre-Market: 09:23
TG Therapeutics Market Cap : 6.050B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 9.029B |
| Precision BioSciences, Inc. | 187.61M |
| AnaptysBio, Inc. | 1.838B |
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Geron Corp. | 827.56M |
Market Cap Related Metrics
| PE Ratio | 13.77 |
| PS Ratio | 9.071 |
| PEG Ratio | 0.0128 |
| Price to Book Value | 10.37 |
| Price | 39.52 |
| Earnings Yield | 7.26% |
| PEGY Ratio | 0.0128 |
| Operating PE Ratio | 42.49 |
| Normalized PE Ratio | 13.55 |